ID

39200

Beschreibung

Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01122251

Link

https://clinicaltrials.gov/show/NCT01122251

Stichworte

  1. 09.12.19 09.12.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

9. Dezember 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Essential Hypertension NCT01122251

Eligibility Essential Hypertension NCT01122251

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients aged between 20 and 75
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
essential hypertension at screening (-3 week)
Beschreibung

Essential Hypertension Screening

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085580
UMLS CUI [1,2]
C0220908
randomization criteria:
Beschreibung

Randomization criteria

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0243161
essential hypertension at baseline (90mmhg≤sitdbp≤109mmhg, except sitsbp≥180)
Beschreibung

Essential Hypertension Baseline | Sitting diastolic blood pressure | Exception Sitting systolic blood pressure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085580
UMLS CUI [1,2]
C1442488
UMLS CUI [2]
C1319894
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1319893
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
mean sitdbp≥110mmhg or sitsbp≥180
Beschreibung

Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1319894
UMLS CUI [1,2]
C0444504
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
secondary hypertension or suspected secondary hypertension
Beschreibung

Secondary hypertension | Secondary hypertension Suspected

Datentyp

boolean

Alias
UMLS CUI [1]
C0155616
UMLS CUI [2,1]
C0155616
UMLS CUI [2,2]
C0750491
uncontrolled diabetes
Beschreibung

Diabetic - poor control

Datentyp

boolean

Alias
UMLS CUI [1]
C0421258
severe heart disease or severe cerebrovascular disease
Beschreibung

Heart Disease Severe | Cerebrovascular Disorder Severe

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0007820
UMLS CUI [2,2]
C0205082
clinically significant hematological test results, renal disease (serum creatinine) or liver disease (alt or ast)
Beschreibung

Hematologic Test Clinical Significance | Kidney Disease | Creatinine measurement, serum | Liver disease | Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018941
UMLS CUI [1,2]
C2826293
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0201976
UMLS CUI [4]
C0023895
UMLS CUI [5]
C0201836
UMLS CUI [6]
C0201899
history of malignant disease
Beschreibung

Malignant disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0442867
autoimmune disease
Beschreibung

Autoimmune Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0004364
women with a positive pregnancy test result, breast feeding or intention of pregnancy during the trial
Beschreibung

Pregnancy test positive | Breast Feeding | Pregnancy intended

Datentyp

boolean

Alias
UMLS CUI [1]
C0240802
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0032961
UMLS CUI [3,2]
C1283828

Ähnliche Modelle

Eligibility Essential Hypertension NCT01122251

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients aged between 20 and 75
boolean
C0001779 (UMLS CUI [1])
Essential Hypertension Screening
Item
essential hypertension at screening (-3 week)
boolean
C0085580 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
Randomization criteria
Item
randomization criteria:
boolean
C0034656 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
Essential Hypertension Baseline | Sitting diastolic blood pressure | Exception Sitting systolic blood pressure
Item
essential hypertension at baseline (90mmhg≤sitdbp≤109mmhg, except sitsbp≥180)
boolean
C0085580 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C1319894 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1319893 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
mean sitdbp≥110mmhg or sitsbp≥180
boolean
C1319894 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Secondary hypertension | Secondary hypertension Suspected
Item
secondary hypertension or suspected secondary hypertension
boolean
C0155616 (UMLS CUI [1])
C0155616 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Diabetic - poor control
Item
uncontrolled diabetes
boolean
C0421258 (UMLS CUI [1])
Heart Disease Severe | Cerebrovascular Disorder Severe
Item
severe heart disease or severe cerebrovascular disease
boolean
C0018799 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0007820 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Hematologic Test Clinical Significance | Kidney Disease | Creatinine measurement, serum | Liver disease | Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
clinically significant hematological test results, renal disease (serum creatinine) or liver disease (alt or ast)
boolean
C0018941 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0201836 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
Malignant disease
Item
history of malignant disease
boolean
C0442867 (UMLS CUI [1])
Autoimmune Disease
Item
autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Pregnancy test positive | Breast Feeding | Pregnancy intended
Item
women with a positive pregnancy test result, breast feeding or intention of pregnancy during the trial
boolean
C0240802 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1283828 (UMLS CUI [3,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video